Plexera Invited to Demonstrate its ProteomicProcessor(TM) at Cold Spring Harbor Laboratory
Lumera zu myNews hinzufügen Was ist das?
Plexera Bioscience LLC, a wholly owned subsidiary of Lumera Corporation
(NASDAQ:LMRA), announced today that it has been invited to demonstrate
its ProteomicProcessor™ Biosensor at the 2007
Proteomics course at Cold Spring Harbor Laboratory. As one of eight
National Cancer Institute-designated basic research centers in the U.S.,
Cold Spring Harbor hosts a series of short courses whereby scientists
from academia and industry gather to learn the latest scientific
advances and to be trained in new cutting-edge technologies. The Cold
Spring Harbor course brings together scientists from all over the world
to present and evaluate new data and ideas in rapidly moving areas of
biological research.
"To be invited to this prestigious course is extremely gratifying and
reflects interest in the broad utility of our ProteomicProcessor™
Biosensor for the growing proteomics market," said Dr. Tim Londergan,
Plexera’s President and COO. "This event gives
us exposure to some of the most renowned scientists in the world in the
field of proteomics and raises our profile in the pharmaceutical
industry."
Plexera has been aggressively pursing presales activities of its
ProteomicProcessor™ platform in anticipation
of the release of the commercial-ready product. Formal launch to the
antibody discovery market is targeted for the May 2008 meeting of PEGS:
The Protein Engineering Summit.
Additional information on the conference can be obtained at http://meetings.cshl.edu/courses/c-proteo07.shtml.
About Plexera Bioscience LLC
Plexera Bioscience LLC was established in July of 2007 as a wholly owned
subsidiary of Lumera Corporation (NASDAQ:LMRA), and is focused on
providing the life sciences market with tools, content, and methods to
simplify and accelerate proteomic discovery for therapeutic antibodies
as well as predictive biomarkers.
About Cold Spring Harbor Laboratory
The Proteomics course at Cold Spring Harbor Laboratory (http://meetings.cshl.edu/courses/c-proteo07.shtml)
is a three-week intensive laboratory and lecture course focusing on two
major themes in proteomics: protein profiling and functional proteomics.
The course receives financial support from the National Cancer Institute
and features world-renowned instructors from academics and industry.
Cold Spring Harbor Laboratory is a private, non-profit basic research
and educational institution. Under the leadership of Dr. Bruce Stillman,
a member of the National Academy of Sciences and a Fellow of the Royal
Society (London), some 330 scientists conduct groundbreaking research in
cancer, neurobiology, plant genetics and bioinformatics. Cold Spring
Harbor Laboratory is one of eight National Cancer Institute-designated
basic research centers in the U.S. and the only such center in the
tri-state area.
Certain statements contained in this release are forward-looking
statements that involve a number of risks and uncertainties. Factors
that could cause actual results to differ materially from those
projected in the company's forward-looking statements include the
following: market acceptance of our technologies and products; our
ability to obtain financing; our financial and technical resources
relative to those of our competitors; our ability to keep up with rapid
technological change; government regulation of our technologies; our
ability to enforce our intellectual property rights and protect our
proprietary technologies; the ability to obtain additional contract
awards and to develop partnership opportunities; the timing of
commercial product launches; the ability to achieve key technical
milestones in key products; and other risk factors identified from time
to time in the company's SEC reports, including its Annual Report on
Form 10-K, and its Quarterly Reports on Form 10-Q.
